April 20, 2017
Alphabet-owned Verily has launched the Project Baseline Study, a collaborative effort with Stanford Medicine and Duke University School of Medicine to amass a large collection of broad phenotypic health data in hopes of developing a well-defined reference of human health.
Project Baseline aims to gather data from around 10,000 participants, each of whom will be followed for four years, and will...
April 17, 2017
Verily has debuted a new health-tracking wearable designed for use in a series of observational and longitudinal studies. With the aptly dubbed Study Watch – which is not available for consumer purchase – the Alphabet subsidiary formerly known as Google Life Sciences aims to push new boundaries in the size, scope and sophistication of wearable data-gathering.
Featuring numerous physiological and...
March 28, 2017
Consistency and dedication may the hallmarks of success for fitness, but that doesn’t mean the apps to support exercise or diet need to be narrow in their focus. Operating on the idea that consumers want flexibility in how they pursue their health goals, Adidas has released a new app that offers a wide variety of content and tracking for multiple aspects of health.
All Day, which is now...
March 1, 2017
After the latest in a series of successful quarters (with $171.2 million in revenue, up 31 percent year over year), DexCom is queuing up some big product launches. On yesterday’s Q4 earnings call, CEO Kevin Sayer provided more detail about the forthcoming G6 continuous glucose monitor as well as the first products to come out of DexCom’s partnership with Verily.
“In a year of much confusion and...
January 26, 2017
Verily, the Alphabet subsidiary formerly known as Google Life Sciences, raised $800 million in funding today from Temasek, a Singapore-based investment company. Temasek will take a minority stake in the company and nominate a member to the company's board.
“Temasek has a history of thoughtful and enduring capital investments, including in life sciences and healthcare, and this commitment to a...
December 5, 2016
Verily -- the Alphabet spinoff formerly known as Google Life Sciences -- has launched a new smart spoon that recognizes uncontrollable or unsteady hand movements at all times and automatically compensates, enabling people to eat without spilling.
The robotic device, Liftware Level, is the second offering from Liftware, a company devoted to developing tools to aid those with motor impairments that...
September 22, 2016
These days, it seems like the digital health world runs increasingly on partnerships. Last week, representatives from three tech companies famous for their partnerships — IBM Watson Health, Qualcomm Life, and Verily Life Sciences (formerly Google X Life Sciences — shared the stage at the Digital Medicine Connect conference in Boston to talk about what makes a good collaboration work.
“I think at...
September 12, 2016
Verily Life Sciences, a division of Google parent company Alphabet, has teamed up with French healthcare company Sanofi to launch Onduo, a diabetes-focused collaboration that leverages Sanofi’s pharmaceutical expertise and Verily’s command of miniaturized electronics, analytics and consumer software development. The two companies together invested about $500 million in Onduo.
The joint venture is...
August 3, 2016
Dexcom’s biggest triumph and its biggest let down this quarter both involved the FDA. On the positive side, a verdict from a special FDA panel means Dexcom may soon be able to change its CGM’s intended use to replace fingerstick glucometers. On the negative side, a voluntary device recall this quarter that potentially affected all of Dexcom’s receivers led to higher-than-expected Q2 losses....
August 2, 2016
UK-based pharmaceutical giant GlaxoSmithKline has partnered with South San Francisco-based Verily to create Galvani Bioelectronics – a joint venture to develop implantable bioelectric medicines, a branch of medicine that works to fight diseases by targeting electrical signals in the body.
Galvani, owned 55 percent by GSK and 45 percent by Verily (formerly known as Google Life Sciences) will have...